Nanobac Pharmaceuticals Incorporated Stock Price on November 19, 2024
| NNBP Stock | USD 0.0001 0.00 0.00% |
Below is the normalized historical share price chart for Nanobac Pharmaceuticals Incorporated extending back to July 18, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Nanobac Pharmaceuticals stands at 0.0001, as last reported on the 2nd of December, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day.
If you're considering investing in Nanobac Stock, it is important to understand the factors that can impact its price. We have found three technical indicators for Nanobac Pharmaceuticals, which you can use to evaluate the volatility of the firm.
As of 12/02/2024, Common Stock is likely to drop to about 14.3 M. In addition to that, Preferred Stock Total Equity is likely to drop to about 280 K. As of 12/02/2024, Price To Sales Ratio is likely to drop to 90.90. In addition to that, Price Earnings Ratio is likely to drop to -5.81. Nanobac Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.0001 | 50 Day MA 0.0001 | Beta (35.70) |
Nanobac |
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| NNBP |
Based on monthly moving average Nanobac Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Nanobac Pharmaceuticals by adding Nanobac Pharmaceuticals to a well-diversified portfolio.
Book Value (0.01) | Enterprise Value 124.8 K | Enterprise Value Ebitda (0.03) | Price Sales 7.0797 | Market Capitalization 124.8 K |
Nanobac Pharmaceuticals Valuation on November 19, 2024
It is possible to determine the worth of Nanobac Pharmaceuticals on a given historical date. On November 19, 2024 Nanobac was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Nanobac Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Nanobac Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nanobac Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Nanobac Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 | |
11/19/2024 | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
| 0.0001 | 0.0001 | 0.0001 | 0.0001 | 1.00 |
| Backtest Nanobac Pharmaceuticals | | | Nanobac Pharmaceuticals History | | | Nanobac Pharmaceuticals Valuation | Previous | Next |
Nanobac Pharmaceuticals Trading Date Momentum on November 19, 2024
| On November 20 2024 Nanobac Pharmaceuticals Incorporated was traded for 0.0001 at the closing time. The top price for the day was 0.0001 and the lowest listed price was 0.0001 . There was no trading activity during the period 1.0. Lack of trading volume on November 20, 2024 did not cause price change. The trading delta at closing time against the current closing price is 0.00% . |
Nanobac Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Nanobac Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Nanobac Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Nanobac financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Nanobac Pharmaceuticals Stock history
Nanobac Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Nanobac is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Nanobac Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Nanobac Pharmaceuticals stock prices may prove useful in developing a viable investing in Nanobac Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Net Loss | -7.6 M | -7.9 M |
Nanobac Pharmaceuticals Stock Technical Analysis
Nanobac Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Nanobac Pharmaceuticals Period Price Range
Low | December 2, 2024
| High |
0.00 | 0.00 |
Nanobac Pharmaceuticals Incorporated cannot be verified against its exchange. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Nanobac Pharmaceuticals December 2, 2024 Market Strength
Market strength indicators help investors to evaluate how Nanobac Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Nanobac Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Nanobac Pharmaceuticals stock market strength indicators, traders can identify Nanobac Pharmaceuticals Incorporated entry and exit signals to maximize returns
Additional Tools for Nanobac Stock Analysis
When running Nanobac Pharmaceuticals' price analysis, check to measure Nanobac Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanobac Pharmaceuticals is operating at the current time. Most of Nanobac Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Nanobac Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanobac Pharmaceuticals' price. Additionally, you may evaluate how the addition of Nanobac Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.